Investor Relations

Rewriting the Health Code

How mRNA technology is shaping the future of medicine

Invitation to join industry roundtable on the future of mRNA technology

The Covid-19 pandemic has ushered in a new era in medicine – that of mRNA technology. But the potential of mRNA for preventing and treating a whole range of diseases goes beyond Covid-19. This industry forum will ask what is next on the horizon for mRNA technology?

Biotech pioneer and professor of biochemistry Pieter Cullis will open this forum with a talk about the beginnings of lipid nanoparticles in the early 1990s, and how they rose to become the industry’s standard technology for the delivery of mRNA and other nucleic acid-based drugs. Our second speaker, Ulrich Blaschke of BioNTech, will discuss the potential future applications of mRNA technologies and shed light on what could be the next breakthrough.

The industry forum is hosted by Evonik Health Care, represented through Maaike Everts and Stefan Randl. As one of the few integrated system solutions providers for the pharma and biotech industries, Evonik’s Maaike Everts and Stefan Randl will take the audience through advanced mixing and formulation technologies for mRNA and other nucleic acids therapeutics.

This event is intended for an open and broader audience of Evonik’s business experts and partners, media contacts as well as analysts & investors.

All participants will have the opportunity to ask questions online via chat during the session.

Document

Link/Download

Invitation incl. Speaker Biographies

Registration

Presentation

follows shortly after the event